| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.85B | 104.29B | 82.52B | 59.28B | 50.31B | 33.93B |
| Gross Profit | 18.07B | 21.34B | 13.62B | 9.84B | 7.09B | 3.58B |
| EBITDA | 9.85B | 18.27B | 12.73B | 9.13B | 6.29B | 2.52B |
| Net Income | 4.01B | 4.74B | 2.95B | 2.33B | 1.25B | ― |
Balance Sheet | ||||||
| Total Assets | 177.31B | 170.37B | 160.66B | 134.60B | 90.72B | 78.31B |
| Cash, Cash Equivalents and Short-Term Investments | 23.20B | 20.08B | 14.83B | 14.13B | 12.59B | 7.69B |
| Total Debt | 56.07B | 54.53B | 57.00B | 50.19B | 20.95B | 12.87B |
| Total Liabilities | 110.94B | 105.99B | 102.09B | 81.34B | 54.03B | 46.52B |
| Stockholders Equity | 45.98B | 44.90B | 37.80B | 33.08B | 32.88B | 29.22B |
Cash Flow | ||||||
| Free Cash Flow | 10.67B | 8.56B | -6.76B | -2.33B | -1.24B | -1.73B |
| Operating Cash Flow | 20.37B | 21.49B | 13.34B | 6.85B | 2.97B | 1.82B |
| Investing Cash Flow | -10.80B | -13.61B | -22.80B | -20.62B | -5.25B | -2.61B |
| Financing Cash Flow | -4.79B | -1.87B | 11.00B | 14.44B | 5.46B | 2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$75.72B | 17.50 | 27.52% | 0.54% | 48.74% | 56.71% | |
67 Neutral | HK$78.22B | 28.72 | 17.43% | 0.16% | 56.67% | 139.25% | |
65 Neutral | HK$913.16B | 10.07 | 35.71% | 1.55% | 22.04% | 75.35% | |
64 Neutral | HK$24.87B | 13.32 | 33.81% | 1.40% | 10.57% | 112.84% | |
63 Neutral | HK$372.28B | 3.27 | 36.30% | ― | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$151.55B | 24.52 | 15.21% | 0.93% | ― | ― |